This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
PathConnect Automates the Pathology Process and Improves Quality of Care
Irving, Texas (PRWEB) February 20, 2014
Miraca Life Sciences, the nations largest independent anatomical pathology lab, today announced the launch a new platform, PathConnect, developed to revolutionize the way a typical physician practice interfaces with its pathology lab, saving hours of valuable time and resources each day.
PathConnect, available for Gastroenterologists, Dermatologists, Hematologist and Urologist practices, allows physicians to create and submit electronic requisitions, automate specimen label creation, view and print daily specimen logs, and access diagnostic reports and status electronically. In addition, physician practices can search and print requisitions and diagnostic reports as well as interface with electronic health records.
Manual requisition and labeling processes are slow, prone to errors, and fraught with specimen collection uncertainty and discrepancies. PathConnect was developed with novel clinical decision support. Testing recommendations and specimen requirements were directed by our expert team of pathologists. A practice management interface includes real-time patient demographic information, eliminating duplication of effort, or errors from manual entry. PathConnect automatically prints copies of requisitions and labels requested by the user, and uses one system to order tests, and view reports.
As a leading pathology service provider, weve always had a focus on technology. We have a strong history of providing workflow efficiencies and solutions to our clients. By combining our extensive experience and expertise, weve created a technology solution that assists healthcare professionals in advancing workflow efficiency, and guides them towards full EHR integration to get the connectivity and automation they need to become Meaningful Use compliant, said Tom Zaves, Senior Vice President of Miraca Life Sciences.
The new Path Connect interactive requisition format is a great tool to employ in physician offices. The program guides the user through the proper steps and prompts them to enter appropriate data, order testing correctly, and indicates the type of specimen needed for a given test. The interface option will aid the office and our staff by uploading accurate demographics and billing data and automatically populate in follow up specimens. The impact on office staff should be significant and ultimately will decrease discrepancy rates in our requisition system. This will then lead to fewer phone calls to gather correct information, which benefits the client, our own client services, and the laboratory staff. An improvement in TAT for basic studies including morphology and flow would be also expected, said Miraca Life Sciences Director of Hematopathology, Michael Miller, MD.
If your practice could benefit from saving hours each day by using PathConnect, visit http://www.MiracaLifeSciences.com or call 866.588.3280.
About Miraca Life Sciences
Serving more than 5,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible technology solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.
Miraca Life Sciences, a wholly-owned subsidiary of Japan-based Miraca Holdings Inc., employs a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It is part of our commitment: not only to scientific excellence, but to patients and practices.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11598828.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.